Back
The Scotts Miracle Gro Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
55
SMG
The Scotts Miracle Gro
Last Price:
73.92
Seasonality Move:
6.03%
Sell
49
RARE
Ultragenyx Pharmaceutical
Last Price:
58.74
Seasonality Move:
-0.7%
Buy
55
The Scotts Miracle Gro (SMG)
is a Buy
Is The Scotts Miracle Gro a Buy, Sell or Hold?
- The current The Scotts Miracle Gro [SMG] share price is $74.55. The Score for SMG is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SMG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.77. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SMG Stock Price Chart
What is The Scotts Miracle Gro's stock price today?
-
The The Scotts Miracle Gro share price today is $74.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMG is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
SMG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 65.78 | Buy |
| Chaikin Money Flow: | 139528 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.39 - 72.55) | Buy |
| Bollinger Bands (100): | (65.13 - 71.35) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | -154927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.53 - 58.27) | Buy |
| Bollinger Bands (100): | (39.73 - 52.87) | Buy |
SMG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.9 | Buy |
| 20-day SMA: | 70.08 | Buy |
| 50-day SMA: | 69.8 | Buy |
| 200-day SMA: | 65.99 | Buy |
| 8-day EMA: | 71.15 | Buy |
| 20-day EMA: | 70.31 | Buy |
| 50-day EMA: | 69.58 | Buy |
| 200-day EMA: | 66.54 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.87 | Buy |
| 20-day SMA: | 57.08 | Buy |
| 50-day SMA: | 51.49 | Buy |
| 200-day SMA: | 46.42 | Buy |
| 8-day EMA: | 57.94 | Buy |
| 20-day EMA: | 56.47 | Buy |
| 50-day EMA: | 52.53 | Buy |
| 200-day EMA: | 46.74 | Buy |
The Scotts Miracle Gro Earnings Growth & SMG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $3.62 per share, an increase this year of $1.80 per share, and an increase next year of $1.16 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
The Scotts Miracle Gro Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||